Navigation Links
IBM and Medical Researchers Launch Effort To Find Flu Drug Treatments
Date:5/5/2009

Lab tests may begin in just weeks as a result of World Community Grid

GALVESTON, Texas, May 5 /PRNewswire-FirstCall/ -- IBM (NYSE: IBM) and the University of Texas Medical Branch (UTMB) launched an effort using IBM's World Community Grid "virtual supercomputer" to allow laboratory tests on drug candidates for drug-resistant influenza strains and new strains, such as H1N1, in less than a month.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO )

Researchers at the University of Texas Medical Branch will use World Community Grid to identify the chemical compounds most likely to stop the spread of the influenza viruses and begin testing these under laboratory conditions. The computational work adds up to thousands of years of computer time which will be compressed into just months using World Community Grid. As many as 10% of the drug candidates identified by calculations on World Community Grid are likely to show antiviral activity in the laboratory and move to further testing.

According to the researchers, without access to World Community Grid's virtual super computing power, the search for drug candidates would take a prohibitive amount of time and laboratory testing. Yet, over the next several months and years, researchers say they hope to identify candidates for clinical tests. The University of Texas researchers are currently using the power of World Community Grid on research projects involving dengue fever and West Nile diseases.

"Because of the experience we gained with our dengue drug p
'/>"/>

SOURCE IBM
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Washington, DC (PRWEB) April 21, 2015 ... operations and Information Technology advisory firm that helps ... technological change, today announced that the Association ... Optimity a Preferred Vendor. ACAP represents 58 local, ... serve more than 13 million people primarily enrolled ...
(Date:4/21/2015)... FL (PRWEB) April 21, 2015 AxoGen, ... on the peripheral nerve repair market, will report results ... 5, 2015 following the close of the market. ... webcast for the investment community following the release at ... phone are invited to call toll free at 1.877.407.0993 ...
(Date:4/21/2015)... April 21, 2015 The PracticeMatch Career ... 5:00 to 8:00 pm at the William and Ida Friday ... NC 27599. More than 50 hospitals, clinics and groups with ... specialties will be represented. Attendees will enjoy free hors d’oeuvres ... Fairs for PracticeMatch says “Chapel Hill is an ...
(Date:4/21/2015)... With a growing number of Americans retiring abroad, ... international political instability and terrorism top the list of ... a global insurance provider with 68 years’ experience covering ... citizenship, also found strong concern but lack of information ... overseas . , Asked to choose the risks of ...
(Date:4/21/2015)... Pharmacy point of sale software ... Independent Pharmacy Cooperative trade show, to be held April ... , Retail Management Solutions recently became an approved vendor ... Gross, VP of Sales and Marketing. Gross says that ... trade shows in the country -- and this new ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:AxoGen, Inc. to Report First Quarter Financial Results on May 5, 2015 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 3Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 2Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 3Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 2Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 3
... 30 Neogen Corporation,(Nasdaq: NEOG ) announces the following Webcast: , ... When: Tuesday, January 6, 2009 @ 11:00 EST, ... Live over the Internet -- Simply log on to the web at ... above., Contact: Terry Maynard of Neogen Corporation, +1-800-234-5333., , ...
... called "the world,s first disposable hearing aid", and is designed ... needing part-time hearing assistance. , ... ... being called "the world,s first disposable hearing aid", and is ...
... impulsive people, New Year,s resolutions often include being ... on dangerous behavior, such as drug use. But ... as novelty seekers by psychologists--face an uphill battle ... the way their brains process dopamine. The research ...
... YORK and BIRMINGHAM, Ala., Dec. 29 Health,Systems Solutions, Inc. ... ) today announced that they have agreed to extend the ... "We are pleased that, with the ... timetable for the completion of the merger and we are ...
... Dec. 29 Curious about your child,s diet,preventing ... or daughter has a sports-related,injury? , ... youth sports coaches, parents and,athletes focused on education, ... Spine (PEAKOrthopedics.com) to answer these questions,through an online, ...
... have lower risks of Alzheimer,s disease and other cognitive ... In more than half of the studies, published since ... had lower dementia risks than nondrinkers. In only a ... a two-edged sword," said Michael Collins, Ph.D., a professor ...
Cached Medicine News:Health News:Supple, Hi-Flex Cable from Cicoil Makes First Disposable Hearing Aid Possible 2Health News:Risk takers, drug abusers driven by decreased ability to process dopamine 2Health News:Health Systems Solutions and Emageon Extend Merger Closing 2Health News:Health Systems Solutions and Emageon Extend Merger Closing 3Health News:SportZu.tv Partners With PEAK Orthopedics & Spine to Launch an Online Sports Doctor's Office 2Health News:Moderate drinking can reduce risks of Alzheimer's dementia and cognitive decline 2
(Date:4/21/2015)... 2015 EUSA Pharma (EUSA), a ... announced the appointment of Lee Morley as ... Non-Executive Director.  Bryan Morton, who established EUSA Pharma as ... Lee Morley joins from Jazz ... of Commercial for Europe and ...
(Date:4/20/2015)... KUALA LUMPUR, Malaysia , April 20, 2015 /PRNewswire/ ... 2015, resulting in a scarcity of opportunities for generic ... drug manufacturers in the region are looking beyond the ... the quality of existing drugs. Certain established generic manufacturers ... research and development of new molecules, although the impact ...
(Date:4/20/2015)... , April 20, 2015 This report analyzes the ... following Product Segments: Non-Powered Breast Pumps, and Powered Breast Pumps. ... Canada , Japan , ... Rest of World. Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
Breaking Medicine Technology:EUSA Pharma Appoints Lee Morley as Chief Executive and Industry Veteran Göran Ando to Board of Directors 2EUSA Pharma Appoints Lee Morley as Chief Executive and Industry Veteran Göran Ando to Board of Directors 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 2Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 4Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 5World Breast Pumps Industry 2World Breast Pumps Industry 3World Breast Pumps Industry 4World Breast Pumps Industry 5World Breast Pumps Industry 6World Breast Pumps Industry 7World Breast Pumps Industry 8World Breast Pumps Industry 9World Breast Pumps Industry 10World Breast Pumps Industry 11World Breast Pumps Industry 12World Breast Pumps Industry 13World Breast Pumps Industry 14
... NEW YORK, Oct. 6 Reportlinker.com announces ... available in its catalogue. , ... Pharma and Biotech , ... The Drug Delivery Partnering Agreements in Pharma ...
... N.J., Oct. 6 Centocor Ortho Biotech Inc. and ... the European Commission has approved SIMPONI(TM) (golimumab) as a ... rheumatoid arthritis (RA), active and progressive psoriatic arthritis (PsA) ... In the European Union, SIMPONI is approved as a ...
Cached Medicine Technology:Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 2Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 3Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 4Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 5Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 6Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 7SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 2SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 3SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 4SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 5SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 6SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 7SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 8SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 9SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 10
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: